Faced with the dramatic escalation of healthcare costs, providers, commercial payers, and the government are testing different methodologies for reimbursing cancer care. The aim is to shift the economics from a fee-for-service environment to a value-based environment that rewards quality, efficiency, and a lower cost of care. However, simply acknowledging the evolving landscape will do little to help oncology providers in preparing and positioning themselves for the transitions ahead. Read this article by Jessica Turgon for Oncology Practice Management to learn about emerging reimbursement methodologies for cancer care and why oncology practices need to be responsive, rather than resistant, to these new payment arrangements.